CymaBay Therapeutics Inc. (CBAY) Q3 2020 Earnings Call Transcript
CBAY earnings call for the period ending September 30, 2020.
CBAY earnings call for the period ending September 30, 2020.
CBAY earnings call for the period ending June 30, 2020.
The development-stage company might be able to resume the development of its lead drug candidate, which was halted in late 2019.
A do-over on one of its drugs is a potential game-changer for CymaBay.
CBAY earnings call for the period ending March 31, 2020.
CBAY earnings call for the period ending December 31, 2019.
Even in a winning market, these stocks fell. Find out why.
The company has halted the development of its lead drug candidate in one indication and terminated two other studies involving the compound.
CBAY earnings call for the period ending September 30, 2019.
Investors will want to pay attention to what Assembly Biosciences, CymaBay Therapeutics, and Madrigal Pharmaceuticals say about their most promising candidate therapies.